Procrit Medicare Charges Would Drop Almost $100 Mil. Using 85% Of AWP
Executive Summary
Reimbursement for Johnson & Johnson's Procrit under Medicare Part B would drop about $100 mil. under a recent proposal to reduce Medicare Part B drug reimbursement by 10.5%
You may also be interested in...
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
Medicare Part B outpatient drug reimbursement would be based either on average sales price or a price determined through competitive bidding under the House Ways & Means Committee's Medicare Rx bill
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
Medicare Part B outpatient drug reimbursement would be based either on average sales price or a price determined through competitive bidding under the House Ways & Means Committee's Medicare Rx bill
Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy
The Senate Finance Committee's Medicare reform bill includes a provision directing HHS to determine actual "market prices" for reimbursement of outpatient drugs currently covered under part B